Metabolic syndrome is also known as metabolic syndrome X, cardiometabolic syndrome, insulin resistance syndrome, syndrome X, CHAOS (in Australia) and Reaven's syndrome. It is a cluster of medical disorders that together increases the risk of developing diabetes and cardiovascular ailments. Generally, metabolic syndrome patients are overweight and hypertensive.
Presence of any three of the following traits in an individual increases his/her chances of developing metabolic syndrome.
Advertisement1.A decrease in serum HDL cholesterol (40mg/dl or less in men and 50mg/dl or less in women)
2.Increase in serum triglycerides (150 mg/dl or above)
3.Presence of high blood pressure (130/85 mm of Hg or more)
4.Fasting glucose level of 100mg/dl or more
Dhayana Dallmeier et al conducted a community-based cross-sectional study that was published in the journal of Diabetology and Metabolic Syndrome 2012. The study aimed at investigating the association between metabolic syndrome and inflammatory biomarkers.
Nine inflammatory biomarkers- interleukin-6, intercellular adhesion molecule-1, C-reactive protein, CD40 ligand, osteoprotegerin, tumor necrosis factor receptor-2, monocyte chemoattractant protein-1, P-selectin and tumor necrosis factor-α, were measured in 2570 participants of the study. The volunteers were free of cardiovascular ailments and diabetes.
The study revealed the presence of metabolic syndrome in 984 participants and was found to be associated with each inflammatory biomarker except osteoprotegerin, thus proving that metabolic syndrome is associated with inflammation even in the absence of obesity. "After adjusting for its components, the metabolic syndrome was only associated with P-selectin."
The study showed the existence of relationship between inflammatory biomarkers and metabolic syndrome. By making adjustments for each component of the metabolic syndrome the relationship between biomarkers and metabolic syndrome was eliminated except for P-selectin.
The researchers concluded, "Our results support the hypothesis that the relation between metabolic syndrome and inflammation is largely accounted for by its components."
Though the findings of the study do not have any immediate clinical significance, further studies in this area could help to find out if measuring inflammatory mediators can predict the development of metabolic syndrome. This could help to institute preventive measures at the earliest.
Metabolic Syndrome and Inflammatory Biomarkers: a community-based cross-sectional Study at the Framingham Heart Study; Dhayana Dallmeier et al; Diabetology and Metabolic Syndrome 2012